Home Medicine Contributors / Teilnehmer
Chapter Publicly Available

Contributors / Teilnehmer

© 2019 Walter de Gruyter GmbH, Berlin/Munich/Boston

© 2019 Walter de Gruyter GmbH, Berlin/Munich/Boston

Chapters in this book

  1. Frontmatter I
  2. Foreword V
  3. Vorwort VII
  4. Begrüßung IX
  5. Begrüßung XI
  6. Contents / Inhaltsverzeichnis XIII
  7. Contributors / Teilnehmer XVII
  8. 1. Theory of coagulation analysis with chromogenic substrates / Theoretische Grundlagen der Gerinnungsanalyse mit chromogenen Substraten
  9. 1.1. Molecular aspects of fibrinogen-fibrin-transition (in English) 1
  10. 1.2. Determination of Protease Activities with Specifically Constructed Peptide-p-Nitroanilide Derivatives / Die Bestimmung von Protease-Aktivitäten mit gezielt konstruierten Peptid-p-Nitroanilid-Derivaten (in German) 23
  11. 1.3. Substrate Structure and Activity Relationship (in English) 37
  12. 2. Determination of thrombin, antithrombin and antifactor X a / Bestimmung von Thrombin, Antithrombin und Antifaktor X a
  13. Einleitung 56
  14. 2.1. Comparison of Six Different Methods for the Quantitative Assay of Antithrombin III (in English) 57
  15. 2.2. Assay of Antithrombin III with the Chromogenic Substrate S-2160 (in English) 61
  16. 2.3. Effects of Thrombin and Low Heparin Concentrations on the Antithrombin Activity in Human Plasma / Einfluß von Thrombin und von geringen Heparin-Konzentrationen auf die Antithrombin-Aktivität in Humanplasma (in German) 69
  17. 2.4. Enzymatic determination of thrombin and thrombin inhibitors (in English) 91
  18. 2.5. Studies on the determination of antithrombin / Untersuchungen zur Bestimmung von Antithrombin (in German) 105
  19. 2.6. Studies on antithrombin III using Chromozym TH (in English) 119
  20. 2.7. Determination of antithrombin III and antifactor X a activity (in English) 123
  21. 3. Determination of prothrombin / Bestimmung von Prothrombin
  22. 3.1. Determination of Plasma Prothrombin with the Chromogenic Peptide Substrate H-D-Phe-Pip-ArgpNA (S-2238) / Bestimmung von Plasma-Prothrombin mit dem chromogenen Peptid-Substrat H-D-Phe-Pip-Arg-pNA (S-2238) (in German) 145
  23. 3.2. Determination of plasma prothrombin with Chromozym TH / Bestimmung von Plasma-Prothrombin mit Chromozym TH (in German) 155
  24. 3.3. Studies on the determination of prothrombin with S-2160 / Untersuchungen zur Prothrombinbestimmung mit S 2160 (in German) 171
  25. 3.4. Amidolytic assay of prothrombin activated with Ecarin, a procoagulant from ECHIS CARINATUS venom (in English) 181
  26. 4. Determination of various coagulation factors / Bestimmu ng verschiedener Gerinnungsfaktoren
  27. 4.1. Assay of Factor Xa with a Chromogenetic Substrate (in English) 203
  28. 4.2. A new assay for plasma kallikrein activity utilizing a synthetic chromogenic substrate (in English) 211
  29. 4.3. Heparin assay in plasma (in English) 221
  30. 4.4. Antiplasmin determination by means of the plasmin specific substrate S-2251- Methodological studies and some clinical applications (in English) 229
  31. 4.5. The quantitative determination of urokinase with Chromozym UK (in English) 249
  32. 4.6. Estimation of urokinase activity by means of a highly susceptible synthetic chromogenic peptide substrate (in English) 251
  33. 5. Possibilities and goals for coagulation analysis with chromogenic substrates / Möglichkeiten und Ziele der Gerinnungsanalytik mit chromogenen Substraten
  34. 5.1. General closing discussion / Allgemeine Abschlußdiskussion (in German) 265
  35. Backmatter 276
Downloaded on 16.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/9783111706153-005/html
Scroll to top button